Compounding Pharmacies - Pharmacist Digest

Compounding pharmacies rebut Novo’s FDA petition

STAT

DECEMBER 4, 2024

Also, compounding pharmacies fire back at Novo Nordisk for its assertion that GLP-1 drugs are too difficult to compound. Sign up to get our biotech newsletter in your inbox. Lots today on GLP-1s: First we see tirzepatide outperforming semaglutide in a head-to-head study in obesity. Read the rest…

Compounding Pharmacies

Compounding Pharmacies Compounding Drug Pricing Drug Development

STAT+: Eli Lilly opens a new legal front in its battle against compounded GLP-1s

STAT

APRIL 23, 2025

To date, Lilly and its rival, Novo Nordisk, have filed dozens of suits against numerous companies involved in compounding versions of semaglutide and tirzepatide, the obesity and diabetes drugs known as GLP-1s. Those lawsuits alleged trademark infringement, false claims and unfair competition, but have so far yielded varying outcomes.

Compounding

Compounding Compounding Pharmacies Diabetes

STAT+: Compounders lose legal battle with FDA over removal of Eli Lilly’s weight loss drug from a shortage list

STAT

MAY 7, 2025

The move means that patients will no longer have access to cheaper versions from compounding pharmacies. Due to ongoing shortages of the Lilly drugs, compounding pharmacies were permitted to make copies that sold for substantially less.

Compounding

Compounding Compounding Pharmacies Diabetes

STAT+: Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA

STAT

OCTOBER 30, 2024

Over the past two years, patients seeking treatment have been turning to compounding pharmacies, which make cheaper copies of branded treatments and are legally allowed to do so only when the branded treatments are listed on the FDA’s shortage list. Continue to STAT+ to read the full story…

Compounding Pharmacies

Compounding Pharmacies Compounding Diabetes

STAT+: Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price

STAT

MARCH 5, 2025

Novo Nordisk will start selling its obesity drug Wegovy directly to patients at a reduced price, following a similar move from Eli Lilly as the two drugmakers compete for market share and try to draw patients away from compounding pharmacies that have been making cheaper copies of weight loss drugs.

Compounding Pharmacies

Compounding Pharmacies Compounding

STAT+: FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period

STAT

DECEMBER 19, 2024

That should have prohibited compounding pharmacies from continuing to make copies of the drug, as they’re allowed to do so only when a treatment is on the shortage list.

Compounding

Compounding Compounding Pharmacies Diabetes

STAT+: FDA and large compound pharmacies settle a long-running dispute over a key list for ingredients

STAT

OCTOBER 12, 2022

Food and Drug Administration and a trade group that represents large compound pharmacies have resolved a long-running dispute over the use of bulk ingredients, clearing the way for some compounded medicines to become available more quickly. Continue to STAT+ to read the full story…

Compounding Pharmacies

Compounding Pharmacies Compounding

Opinion: Compounding pharmacies offer a fix for shortages of essential drugs

STAT

MAY 15, 2023

At the urging of the Alliance for Pharmacy Compounding, the trade association I lead, the Food and Drug Administration in April 2020 issued temporary guidance allowing traditional compounding pharmacies, within tight regulatory guardrails, to prepare 13 Covid drugs from pure ingredients to meet hospitals’ urgent need.

Compounding Pharmacies

Compounding Pharmacies Compounding Hospitals

STAT+: Court ruling opens door to FDA action against Ozempic compounders

STAT

APRIL 25, 2025

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy. Compounding pharmacies are legally allowed to make versions of branded treatments if the drugs are deemed to be in shortage by the FDA.

Compounding

Compounding Compounding Pharmacies Diabetes

STAT+: The end of compounded GLP-1 copies leaves many patients in a ‘lose-lose’ position

STAT

APRIL 29, 2025

The explosion of compounded GLP-1 offerings over the past two years is coming to an end, and many patients are left with no good options. Now, hundreds of thousands of patients are stuck navigating uncharted waters as companies they entrusted with their health pursue strategies that may disrupt their care or present risks.

Compounding

Compounding Compounding Pharmacies Diabetes

STAT+: In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list

STAT

OCTOBER 11, 2024

The Food and Drug Administration on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, from its shortage list, and, for the time being, would not pursue regulatory action against certain compounding pharmacies making copies of the drugs.

Compounding Pharmacies

Compounding Pharmacies Compounding Diabetes

STAT+: Novo asks FDA to bar compounders from making Ozempic copies

STAT

OCTOBER 22, 2024

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex for the pharmacies to safely make.

Compounding

Compounding Compounding Pharmacies Documentation Diabetes

STAT+: Pharmalittle: We’re reading about copycat weight loss drugs, ADHD prescriptions spiking, and more

STAT

MARCH 20, 2025

Food and Drug Administration wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies that have fueled widespread use of the knockoffs have other plans , The Wall Street Journal writes. We appreciate any and all thoughts and suggestions. … The U.S.

Compounding Pharmacies

Compounding Pharmacies Compounding Dosage

STAT+: Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro

STAT

SEPTEMBER 20, 2023

As the gold rush over weight-loss drugs accelerates, Eli Lilly filed lawsuits against several compounding pharmacies, spas and wellness centers around the U.S. The drug company accused four compound pharmacies of violating state laws because those versions were not approved by the U.S.

Compounding

Compounding Compounding Pharmacies Diabetes

Are Compounding Pharmacies Safe? Everything You Need to Know

Compounding Pharmacy of America

DECEMBER 23, 2024

Learn how compounding pharmacies ensure safety and reliability through rigorous standards, sterile preparations, and personalized solutions for unique healthcare needs. The post Are Compounding Pharmacies Safe? Everything You Need to Know appeared first on Compounding Pharmacy of America.

Compounding Pharmacies

Compounding Pharmacies Compounding

STAT+: Judge dismisses Novo Nordisk lawsuit over compounded versions of Ozempic and Wegovy

STAT

OCTOBER 6, 2023

judge dismissed its lawsuit accusing a compound pharmacy of selling versions of its Wegovy and Ozempic medicines, which are widely prescribed for weight loss and have become franchise products for the drug company. The drug maker argued the compounders were selling versions of its medicines that were never approved by the U.S.

Compounding

Compounding Compounding Pharmacies

STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight

STAT

OCTOBER 25, 2024

By law, that should have prohibited compound pharmacies from making copies of the drug, as they’re allowed to do so only when the treatment is on the shortage list.

Compounding Pharmacies

Compounding Pharmacies Compounding Diabetes

STAT+: Compounding group sues FDA for removing Lilly’s obesity drug from its shortages list

STAT

OCTOBER 8, 2024

A trade group representing large compounding pharmacies has sued the U.S. Food and Drug Administration for a “reckless and arbitrary” decision to remove a widely prescribed Eli Lilly drug for combating diabetes and obesity from an official shortages list.

Compounding

Compounding Compounding Pharmacies Diabetes Drug Pricing

Don’t Ignore Erectile Dysfunction

Compounding Pharmacy of America

DECEMBER 6, 2024

Addressing ED is not just about improving […] The post Dont Ignore Erectile Dysfunction appeared first on Compounding Pharmacy of America.

Compounding Pharmacies

Compounding Pharmacies Compounding Diabetes

STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight

STAT

OCTOBER 25, 2024

By law, that should have prohibited compound pharmacies from making copies of the drug, as they’re allowed to do so only when the treatment is on the shortage list.

Compounding Pharmacies

Compounding Pharmacies Compounding Diabetes

STAT+: Pharmalittle: AbbVie buys Immunogen, maker of targeted cancer drugs; Novo sues two more compounders

STAT

NOVEMBER 30, 2023

Novo Nordisk filed lawsuits against two compounding pharmacies for selling adulterated and misbranded compounded drugs claiming to contain semaglutide, the active ingredient in Wegovy and Ozempic (see here and here ). Testing of compounded drugs from these pharmacies revealed unknown impurities up to 33%, the company claims.

Compounding

Compounding Compounding Pharmacies Chemotherapy

STAT+: Pharmalittle: Lilly sues spas and compounders over ‘unapproved’ Mounjaro; nasal-spray EpiPen alternative suffers setback

STAT

SEPTEMBER 20, 2023

… As the gold rush over weight-loss drugs accelerates, Eli Lilly filed lawsuits against several compounding pharmacies, spas and wellness centers around the U.S. The drug company accused four compound pharmacies of violating state laws because those versions were not approved by the U.S.

Compounding

Compounding Compounding Pharmacies Diabetes

Comprehensive Nationwide Compounding Pharmacy Services

Compounding Pharmacy of America

JANUARY 2, 2025

Learn about our compounding pharmacy services and shipping areas. The post Comprehensive Nationwide Compounding Pharmacy Services appeared first on Compounding Pharmacy of America. Serving patients across the U.S. with custom medications tailored to your needs.

Compounding Pharmacies

Compounding Pharmacies Compounding

STAT+: Pharmalittle: We’re reading about Novo targeting compounded obesity drugs, an Amgen ‘at risk’ launch, and more

STAT

OCTOBER 23, 2024

Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex for the pharmacies to safely make , STAT reports. … Novo Nordisk has asked the U.S.

Compounding

Compounding Compounding Pharmacies Biosimilars Documentation

GLP-1 compounding is still in limbo. Will the FDA leave it for the next administration?

PharmaVoice

DECEMBER 11, 2024

The agency has yet to make a decision about keeping tirzepatide on or off of its shortage list — letting compound pharmacies continue their lucrative operations for now.

Compounding

Compounding Compounding Pharmacies

Beyond one-size-fits-all: How compounding pharmacies address allergies with precision

pharmaphorum

JUNE 7, 2024

Discover how compounding pharmacies use genetic information to create precision medications tailored to individual allergies. Learn how personalised treatments can benefit you.

Compounding Pharmacies

Compounding Pharmacies Compounding

STAT+: FDA inspection underscores problem at major U.S. compounder behind hospital drug recalls

STAT

JULY 26, 2023

One of the largest compound pharmacy operations in the U.S. facility run by Central Admixture Pharmacy Services. recently recalled a slew of injectable medicines used by hospitals over concerns about possible side effects and a newly released regulatory report underscores the extent of the problem.

Compounding

Compounding Hospitals Compounding Pharmacies

STAT+: More hospital pharmacists are rationing drugs due to increasing shortages

STAT

AUGUST 11, 2023

At the same time, more pharmacists are changing their purchasing practices, with nine out of 10 pivoting toward different vial sizes or concentrations, while 59% percent are buying more from compounding pharmacies.

Hospitals

Hospitals Compounding Pharmacies Dosage Chemotherapy

5 Reasons to Use a Compounding Pharmacy

Compounding Pharmacy of America

DECEMBER 23, 2024

Discover five key reasons to choose a compounding pharmacy, from personalized medications to allergy-free formulations and tailored solutions for unique needs. The post 5 Reasons to Use a Compounding Pharmacy appeared first on Compounding Pharmacy of America.

Compounding Pharmacies

Compounding Pharmacies Compounding

How Compounding Pharmacies Help Seniors Easily Manage Prescriptions

Compounding Pharmacy of America

DECEMBER 26, 2024

Discover how compounding pharmacies provide custom solutions for seniors, improving medication adherence, reducing side effects, and enhancing quality of life. The post How Compounding Pharmacies Help Seniors Easily Manage Prescriptions appeared first on Compounding Pharmacy of America.

Compounding Pharmacies

Compounding Pharmacies Compounding

ASBM Statement on FDA Announcing End of 2-Year GLP-1 Shortage

Safe Biologics

MARCH 5, 2025

During the shortage, compounding pharmacies were permitted to increase patient access to these medications by compounding their own version. Both drugs have been on the FDAs drug shortage list since 2022. But with the shortage over, this is no longer the case.

Compounding Pharmacies

Compounding Pharmacies Compounding Diabetes

STAT+: Pharmalittle: Manufacturers say bird flu shots for humans can be made quickly; obesity guidelines for children disappoint

STAT

MARCH 20, 2023

And some people are turning to compounding pharmacies for the hard-to-get weight-loss drugs. … Either due to cost or ongoing shortages, people are seeking alternatives to the brand name medications Ozempic and Wegovy, both of which contain the active ingredient semaglutide, NBC News tells us.

Compounding Pharmacies

Compounding Pharmacies Compounding

STAT+: Pharmalittle: We’re reading about the FDA listing Novo drugs as ‘available,’ pharma layoffs, and more

STAT

OCTOBER 31, 2024

Food and Drug Administration drug shortage list as of Wednesday , raising the possibility that the medications could soon be taken off the list entirely, a development that could affect compounding pharmacies and patients relying on compounded drugs, STAT reports.

Compounding Pharmacies

Compounding Pharmacies Compounding Diabetes Packaging

Zepbound, Mounjaro shortages are resolved, FDA confirms

PharmaVoice

DECEMBER 20, 2024

The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a limited grace period before taking any enforcement actions.

Compounding Pharmacies

Compounding Pharmacies Compounding

The Role of Compounding Pharmacies in Meeting Patient Needs

Pharmaceutical Commerce

JANUARY 16, 2025

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Donald Prentiss, founder and CEO, Qualthera, comments on the role that compounding pharmacies play in the pharmaceutical supply chain from a macro perspective.

Compounding Pharmacies

Compounding Pharmacies Compounding

Novo Nordisk Calls for FDA to Prohibit Compounding Pharmacies from Providing Semaglutide

Pharmacy Times

OCTOBER 25, 2024

The call follows the FDA’s sudden removal of tirzepatide from the drug shortage list, preventing compounding pharmacies from providing the drug.

Compounding Pharmacies

Compounding Pharmacies Compounding

STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties

STAT

SEPTEMBER 22, 2023

When a comparable drug is not available, 29% turn to their pharmacy’s compounding services, while 6% look to another compounding pharmacy. And 72% said shortages very significantly or significantly impact their workflow. Continue to STAT+ to read the full story…

Department of Veterans Affairs

Department of Veterans Affairs Pharmacy Technician Compounding Pharmacies Compounding

Customized Medication for Chronic Pain

Compounding Pharmacy of America

DECEMBER 27, 2024

Compounded medicationscustomized formulations tailored to an individuals unique […] The post Customized Medication for Chronic Pain appeared first on Compounding Pharmacy of America.

Compounding Pharmacies

Compounding Pharmacies Compounding

Rising Demand for Customized Medication To Transform Compounding Pharmacies Market Outlook

Pharma Mirror

APRIL 16, 2021

Compounding pharmacies, which involve the preparation and selling of prescribed medicines are gaining massive popularity across the healthcare sector owing to the rising awareness regarding the benefits of compounded medications.

Compounding Pharmacies

Compounding Pharmacies Compounding Community Pharmacies

Is Compounding Pharmacy Right For You?

The Happy PharmD

JULY 4, 2024

Are you considering a career in compounding pharmacy? Let me take you on a journey into the world of compounding pharmacists, where we dive into everything from job satisfaction to salary expectations. The post Is Compounding Pharmacy Right For You? appeared first on The Happy PharmD.

Compounding Pharmacies

Compounding Pharmacies Compounding Sterile Compounds Independent Pharmacies

How Microbial Preservation Supports Quality and Safety in Compounding Pharmacies

Pharmacy Times

APRIL 4, 2025

Mark Mulvahill, MBA, MSc, discusses the importance of microbial preservation and reference materials in pharmaceutical manufacturing and compounding pharmacies, highlighting their role in contamination control, regulatory compliance, and enhancing microbiological testing reliability.

Compounding Pharmacies

Compounding Pharmacies Compounding Pharmaceutical Manufacturing

Diabetes advocacy group discourages use of compounded GLP-1 drugs

BioPharma Dive

DECEMBER 2, 2024

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.

Compounding

Compounding Compounding Pharmacies Diabetes

FDA rethinking block on compounding of Lilly's obesity drug

pharmaphorum

OCTOBER 14, 2024

Faced with lawsuit, FDA rethinks block on compounding pharmacies making Eli Lilly's diabetes and obesity drug tirzepatide

Compounding

Compounding Compounding Pharmacies Diabetes

Novo joins Lilly in asking FDA for ban on GLP-1 compounding

pharmaphorum

OCTOBER 23, 2024

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by these manufacturers.

Compounding

Compounding Compounding Pharmacies Diabetes

Compounding pharmacies rebut Novo’s FDA petition

STAT+: Eli Lilly opens a new legal front in its battle against compounded GLP-1s

Trending Sources

STAT+: Compounders lose legal battle with FDA over removal of Eli Lilly’s weight loss drug from a shortage list

STAT+: Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA

STAT+: Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price

STAT+: FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period

STAT+: FDA and large compound pharmacies settle a long-running dispute over a key list for ingredients

Opinion: Compounding pharmacies offer a fix for shortages of essential drugs

STAT+: Court ruling opens door to FDA action against Ozempic compounders

STAT+: The end of compounded GLP-1 copies leaves many patients in a ‘lose-lose’ position

STAT+: In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list

STAT+: Novo asks FDA to bar compounders from making Ozempic copies

STAT+: Pharmalittle: We’re reading about copycat weight loss drugs, ADHD prescriptions spiking, and more

STAT+: Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro

Are Compounding Pharmacies Safe? Everything You Need to Know

STAT+: Judge dismisses Novo Nordisk lawsuit over compounded versions of Ozempic and Wegovy

STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight

STAT+: Compounding group sues FDA for removing Lilly’s obesity drug from its shortages list

Don’t Ignore Erectile Dysfunction

STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight

STAT+: Pharmalittle: AbbVie buys Immunogen, maker of targeted cancer drugs; Novo sues two more compounders

STAT+: Pharmalittle: Lilly sues spas and compounders over ‘unapproved’ Mounjaro; nasal-spray EpiPen alternative suffers setback

Comprehensive Nationwide Compounding Pharmacy Services

STAT+: Pharmalittle: We’re reading about Novo targeting compounded obesity drugs, an Amgen ‘at risk’ launch, and more

GLP-1 compounding is still in limbo. Will the FDA leave it for the next administration?

Beyond one-size-fits-all: How compounding pharmacies address allergies with precision

STAT+: FDA inspection underscores problem at major U.S. compounder behind hospital drug recalls

STAT+: More hospital pharmacists are rationing drugs due to increasing shortages

5 Reasons to Use a Compounding Pharmacy

How Compounding Pharmacies Help Seniors Easily Manage Prescriptions

ASBM Statement on FDA Announcing End of 2-Year GLP-1 Shortage

STAT+: Pharmalittle: Manufacturers say bird flu shots for humans can be made quickly; obesity guidelines for children disappoint

STAT+: Pharmalittle: We’re reading about the FDA listing Novo drugs as ‘available,’ pharma layoffs, and more

Zepbound, Mounjaro shortages are resolved, FDA confirms

The Role of Compounding Pharmacies in Meeting Patient Needs

Novo Nordisk Calls for FDA to Prohibit Compounding Pharmacies from Providing Semaglutide

STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties

Customized Medication for Chronic Pain

Rising Demand for Customized Medication To Transform Compounding Pharmacies Market Outlook

Is Compounding Pharmacy Right For You?

How Microbial Preservation Supports Quality and Safety in Compounding Pharmacies

Diabetes advocacy group discourages use of compounded GLP-1 drugs

FDA rethinking block on compounding of Lilly's obesity drug

Novo joins Lilly in asking FDA for ban on GLP-1 compounding

Stay Connected